Library

By /

Clear

Displaying 426 - 450 of 2,995

ADCs: Other Novel Targets and Pathways
ADCs: Other Novel Targets and Pathways
By: Cynthia X. Ma, MD, PhD
Immunotherapy for Breast Cancer
Immunotherapy for Breast Cancer
By: D. Constanza Guaqueta, MD
Proteomics: The Promise for the Future
Proteomics: The Promise for the Future
By: Emanuel F. “Chip” Petricoin, PhD
Innovation in Tackling Triple Negative Residual Disease Following Preoperative KN-522 Regimen
Innovation in Tackling Triple Negative Residual Disease Following Preoperative KN-522 Regimen
By: Heather McArthur, MD
Immunotherapy and Optimal Chemotherapy for Early Stage TNBC: When and in Whom?
Immunotherapy and Optimal Chemotherapy for Early Stage TNBC: When and in Whom?
By: Hope Rugo, MD, FASCO
Novel Endocrine Therapies
Novel Endocrine Therapies
By: Irene Kang, MD
Response Predictors for Breast Cancer Immunotherapy
Response Predictors for Breast Cancer Immunotherapy
By: Isaac Chan, MD
ILC, When Non-scary Becomes Scary
ILC, When Non-scary Becomes Scary
By: Jason Aboudi Mouabbi, MD
  View PDF
Next Generation in Targeting DNA Repair
Next Generation in Targeting DNA Repair
By: Jennifer Litton, MD
Neoadjuvant Endocrine Therapy
Neoadjuvant Endocrine Therapy
By: Jo Chien, MD
New Biomarkers in Breast Cancer
New Biomarkers in Breast Cancer
By: Joanne Mortimer, MD, FACP, FASCO
  View PDF
New Biomarkers in Breast Cancer
New Biomarkers in Breast Cancer
By: Joanne Mortimer, MD, FACP, FASCO
  View Video